Package 51754-0203-2

{"route": ["INTRAVENOUS"], "spl_id": "d053ac54-7922-4e79-a5a2-62eb3c2c3f4d", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["1665057", "1665061"], "spl_set_id": ["eff5e83b-f819-4a5b-9746-12bce328d7a7"], "manufacturer_name": ["EXELA PHARMA SCIENCES, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 VIAL in 1 CARTON (51754-0203-2)  / 2 mL in 1 VIAL", "package_ndc": "51754-0203-2", "marketing_start_date": "20160422"}, {"sample": false, "description": "25 VIAL in 1 CARTON (51754-0203-4)  / 2 mL in 1 VIAL", "package_ndc": "51754-0203-4", "marketing_start_date": "20161209"}], "brand_name": "Verapamil Hydrochloride", "product_id": "51754-0203_d053ac54-7922-4e79-a5a2-62eb3c2c3f4d", "dosage_form": "INJECTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "51754-0203", "generic_name": "Verapamil Hydrochloride", "labeler_name": "EXELA PHARMA SCIENCES, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "NDA018925", "marketing_category": "NDA", "marketing_start_date": "20160422", "listing_expiration_date": "20261231"}